Zepbound Slashes Diabetes Risk in Obese Users
WEDNESDAY, Nov. 27, 2024 -- The cutting-edge weight-loss drug Zepbound can protect obese people from developing type 2 diabetes, a new clinical trial has found.
Zepbound reduced the risk of diabetes in obese prediabetic patients by more than 90%...